journal article·2023-02-14Open access

A Novel Dressing Composed of Adipose Stem Cells and Decellularized Wharton’s Jelly Facilitated Wound Healing and Relieved Lymphedema by Enhancing Angiogenesis and Lymphangiogenesis in a Rat Model

Jen-Her Lu, Kai Hsia, Chih-Kuan Su, Yi-Hsiang Pan, Hsu Ma, Shih-Hwa Chiou, Chih-Hsun Lin

Abstract

Lymphedema causes tissue swelling due to the accumulation of lymphatic fluid in the tissue, which delays the process of wound-healing. Developing effective treatment options of lymphedema is still an urgent issue. In this study, we aim to fabricate tissue-engineered moist wound dressings with adipose stem cells (ASCs) and decellularized Wharton’s jelly (dWJ) from the human umbilical cord in order to ameliorate lymphedema. Rat ASCs were proliferated and an apparent layer was observed on dWJ at day 7 and 14. A rat tail lymphedema model was developed to evaluate the efficacy of the treatment. Approximately 1 cm of skin near the base of the rat tail was circularly excised. The wounds were treated by secondary healing (control) (n = 5), decellularized Wharton’s jelly (n = 5) and ASC-seeded dWJ (n = 5). The wound-healing rate and the tail volume were recorded once a week from week one to week five. Angiogenesis and lymphangiogenesis were assessed by immunochemistry staining with anti-CD31 and anti-LYVE1. The results showed that the wound-healing rate was faster and the tail volume was lesser in the ASC-seeded dWJ group than in the control group. More CD31+ and LYVE-1+ cells were observed at the wound-healing area in the ASC-seeded dWJ group than in the control group. This proves that tissue-engineered moist wound dressings can accelerate wound-healing and reduce lymphedema by promoting angiogenesis and lymphangiogenesis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lymphatic System and Diseases · Body Contouring and Surgery · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pediatrics, Taipei Veterans General Hospital, Taipei 11217, Taiwan

Section of Pediatric Cardiology, Department of Pediatrics, Taipei Medical University Hospital, Taipei 11031, Taiwan

Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan

Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan

Department of Surgery, School of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan

Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei 300093, Taiwan

Funding

Taipei Veterans General Hospital · Taiwan Ministry of Science and Technology

References (77)

Show source-provided references
1. Lymphedema: Classification, diagnosis and therapy10.1177/1358836X9800300209 ↗
2. Executive Committee of the International Society of Lymphology (2003). The diagnosis and treatment of peripheral lymphedema. Lymphology, 36, 84–91.
3. Cheng, M.-H., Chang, D.W., and Patel, K.M. (2015). Principles and Practice of Lymphedema Surgery, Elsevier Health Sciences.10.1016/B978-0-323-29897-1.00001-2 ↗
4. Zampell, J.C., Yan, A., Elhadad, S., Avraham, T., Weitman, E., and Mehrara, B.J. (2012). CD4+ cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS ONE, 7.10.1371/journal.pone.0049940 ↗
5. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema10.1096/fj.12-222695 ↗
6. Savetsky, I.L., Ghanta, S., Gardenier, J.C., Torrisi, J.S., Nores, G.D.G., Hespe, G.E., Nitti, M.D., Kataru, R.P., and Mehrara, B.J. (2015). Th2 cytokines inhibit lymphangiogenesis. PLoS ONE, 10.10.1371/journal.pone.0126908 ↗
7. Impaired lymphatic contraction associated with immunosuppression10.1073/pnas.1116152108 ↗
8. Cationic, anionic and neutral polysaccharides for skin tissue engineering and wound healing applications10.1016/j.ijbiomac.2021.10.013 ↗
9. Lymphovenous Anastomosis Aids Wound Healing in Lymphedema: Relationship between Lymphedema and Delayed Wound Healing from a View of Immune Mechanisms10.1089/wound.2018.0871 ↗
10. Lymphedema: A comprehensive review10.1097/01.sap.0000257149.42922.7e ↗
11. Review of the evidence of lymphedema treatment effect10.1097/PHM.0000000000000246 ↗
12. Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care
13. Yoshida, S., Koshima, I., Imai, H., Roh, S., Mese, T., Uchiki, T., Sasaki, A., and Nagamatsu, S. (2021). Effect of Postoperative Compression Therapy on the Success of Liposuction in Patients with Advanced Lower Limb Lymphedema. J. Clin. Med., 10.10.3390/jcm10214852 ↗
14. Surgical treatment of lymphedema10.1097/PRS.0000000000005993 ↗
15. Application and prospect of adipose stem cell transplantation in treating lymphedema10.4252/wjsc.v12.i7.676 ↗
16. Concise review: The use of adipose-derived stromal vascular fraction cells and platelet rich plasma in regenerative plastic surgery10.1002/stem.2498 ↗
17. Breast reconstruction with enhanced stromal vascular fraction fat grafting: What is the best method?10.1097/GOX.0000000000000285 ↗
18. Adipose-derived stem cells for wound healing10.1002/jcp.27922 ↗
19. Cell sheet composed of adipose-derived stem cells demonstrates enhanced skin wound healing with reduced scar formation10.1016/j.actbio.2018.07.022 ↗
20. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine10.1002/stem.1076 ↗
21. Paracrine effects of adipose-derived stem cells promote lymphangiogenesis in irradiated lymphatic endothelial cells10.1097/PRS.0000000000005669 ↗
22. Adipose-derived stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors10.1097/SAP.0000000000000084 ↗
23. Lymphedema: Pathogenesis and novel therapies10.1146/annurev-med-060116-022900 ↗
24. Inflammation-induced lymphangiogenesis and lymphatic dysfunction10.1007/s10456-014-9416-7 ↗
25. Modification of a rodent hindlimb model of secondary lymphedema: Surgical radicality versus radiotherapeutic ablation10.1155/2013/208912 ↗
26. Animal models of secondary lymphedema: New approaches in the search for therapeutic options10.1089/lrb.2016.0015 ↗
27. Wharton’s jelly derived mesenchymal stem cells: Future of regenerative medicine? Recent findings and clinical significance10.1155/2015/430847 ↗
28. Mesenchymal Stem Cells Derived from Umbilical Cord Blood Having Excellent Stemness Properties with Therapeutic Benefits—A New Era in Cancer Treatment10.2174/1574888X17666220425102154 ↗
29. Stromal differentiation and architecture of the human umbilical cord10.1016/S0143-4004(97)90071-0 ↗
30. Umbilical cord-derived Wharton’s jelly for regenerative medicine applications10.1186/s13018-020-1553-7 ↗
31. Microfibrillar composition of umbilical cord matrix: Characterization of fibrillin; collagen VI and intact collagen V10.1016/S0143-4004(98)90104-7 ↗
32. Wharton’s jelly as a reservoir of peptide growth factors10.1016/j.placenta.2004.10.008 ↗
33. Extracellular Matrix from Decellularized Wharton’s Jelly Improves the Behavior of Cells from Degenerated Intervertebral Disc10.3389/fbioe.2020.00262 ↗
34. Decellularized Wharton’s jelly extracellular matrix as a promising scaffold for promoting hepatic differentiation of human induced pluripotent stem cells10.1002/jcb.27965 ↗
35. Fabrication of a three dimensional spongy scaffold using human Wharton’s jelly derived extra cellular matrix for wound healing10.1016/j.msec.2017.04.074 ↗
36. Lanza, R., Langer, R., Vacanti, J.P., and Atala, A. (2020). Principles of Tissue Engineering, Academic Press.
37. Tissue-engineered lymphatic graft for the treatment of lymphedema10.1016/j.jss.2014.07.059 ↗
38. Lymphatic vessels in regenerative medicine and tissue engineering10.1089/ten.teb.2016.0034 ↗
39. Evaluation of lymphangiogenesis in acellular dermal matrix
40. Volume measurement in lymphoedema treatment: Examination of formulae10.1111/j.1365-2354.1995.tb00047.x ↗
41. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo10.1161/CIRCULATIONAHA.108.793208 ↗
42. Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema10.1093/jjco/hyr055 ↗
43. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel10.1016/j.biomaterials.2011.02.051 ↗
44. Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells10.1161/JAHA.112.000877 ↗
45. Cell transplantation therapy for a rat model of secondary lymphedema10.1016/j.jss.2013.11.1116 ↗
46. Impact of platelet rich plasma and adipose stem cells on lymphangiogenesis in a murine tail lymphedema model10.1016/j.mvr.2015.09.001 ↗
47. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model10.2217/rme.15.24 ↗
48. Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function10.1172/jci.insight.89081 ↗
49. Adipose-Derived Stem Cells and Vascularized Lymph Node Transfers Successfully Treat Mouse Hindlimb Secondary Lymphedema by Early Reconnection of the Lymphatic System and Lymphangiogenesis10.1097/PRS.0000000000003110 ↗
50. Multipotent Adult Progenitor Cells Support Lymphatic Regeneration at Multiple Anatomical Levels during Wound Healing and Lymphedema10.1038/s41598-018-21610-8 ↗
51. Aligned nanofibrillar collagen scaffolds—Guiding lymphangiogenesis for treatment of acquired lymphedema10.1016/j.biomaterials.2016.05.040 ↗
52. Interstitial flow as a guide for lymphangiogenesis10.1161/01.RES.0000065621.69843.49 ↗
53. TGF-β1 is a negative regulator of lymphatic regeneration during wound repair10.1152/ajpheart.00879.2008 ↗
54. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema10.1152/ajpcell.00378.2010 ↗
55. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling10.1016/j.biomaterials.2017.03.033 ↗
56. Spatio-temporal models of lymphangiogenesis in wound healing10.1007/s11538-016-0205-x ↗
57. Relationship between lymphangiogenesis and exudates during the wound-healing process of mouse skin full-thickness wound10.1111/j.1524-475X.2009.00512.x ↗
58. Expression of VEGFR-3 and 5′-Nase in regenerating lymphatic vessels of the cutaneous wound healing10.1002/jemt.20082 ↗
59. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing10.1016/S0002-9440(10)65021-3 ↗
60. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing10.2353/ajpath.2007.060018 ↗
61. Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair
62. Cooperative effects of vascular angiogenesis and lymphangiogenesis10.1007/s40883-018-0054-2 ↗
63. Histologic analysis of angiogenesis and lymphangiogenesis in acellular human dermis10.1097/01.prs.0000302505.43942.07 ↗
64. Jadalannagari, S., Converse, G., McFall, C., Buse, E., Filla, M., Villar, M.T., Artigues, A., Mellot, A.J., Wang, J., and Detamore, M.S. (2017). Decellularized Wharton’s Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications. PLoS ONE, 12.10.1371/journal.pone.0172098 ↗
65. Nanofibrillar Decellularized Wharton’s Jelly Matrix for Segmental Tracheal Repair10.1002/adfm.201910067 ↗
66. The human umbilical vein with Wharton’s jelly as an allogeneic, acellular construct for vocal fold restoration10.1089/ten.tea.2009.0064 ↗
67. Decellularized Wharton jelly matrix: A biomimetic scaffold for ex vivo hematopoietic stem cell culture10.1182/bloodadvances.2018019315 ↗
68. Nanofibrous Wharton’s jelly scaffold in combination with adipose-derived stem cells for cartilage engineering10.1016/j.matdes.2019.108216 ↗
69. Nonvenous origin of dermal lymphatic vasculature10.1161/CIRCRESAHA.116.306170 ↗
70. In vitro induction of human adipose-derived stem cells into lymphatic endothelial-like cells10.1089/cell.2014.0043 ↗
71. Paracrine effect of human adipose-derived stem cells on lymphatic endothelial cells10.2217/rme-2020-0071 ↗
72. Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart10.1016/j.biomaterials.2014.04.114 ↗
73. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke10.1002/stem.1024 ↗
74. Matrix-bound nanovesicles within ECM bioscaffolds10.1126/sciadv.1600502 ↗
75. Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine10.1007/s13238-015-0179-8 ↗
76. Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis10.1186/s12951-020-00755-7 ↗
77. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels10.1002/dvdy.21605 ↗